scispace - formally typeset
P

Peter J. Barnes

Researcher at National Institutes of Health

Publications -  1554
Citations -  177909

Peter J. Barnes is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Asthma & COPD. The author has an hindex of 194, co-authored 1530 publications receiving 166618 citations. Previous affiliations of Peter J. Barnes include University of Nebraska Medical Center & Novartis.

Papers
More filters
Journal ArticleDOI

Review of exhaled nitric oxide in chronic obstructive pulmonary disease

TL;DR: Routine serial measurements of F(E)NO for clinical asthma management does not appear warranted and the role of add-on monitoring of exhaled NO to GOLD management guidelines is less clear because of the absence of conclusive doubleblind, randomized, control trial studies concerning potential clinical benefits in the management of COPD.
Reference BookDOI

Neuropeptides in respiratory medicine

TL;DR: Part 1 Innervation of the Airways: Neuropeptides and Classic Innervation - Neural Structures in Human Airways Functional Autonomic Innervation in the Airways - The Cholinergic and Adrenergic Systems NeuropePTides in the Lower Airways Investigated by Modem Microscopy Neural Control of the Upper Respiratory Tract Peptide Biosynthesis and Secretion.
Journal ArticleDOI

Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.

TL;DR: The inability of drugs which increase tissue cyclic GMP content and exhibit anti‐spasmogenic activity to inhibit methacholine‐stimulated Ins(1,4,5)P3 formation suggests that, unlike vascular smooth muscle, cyclicGMP‐dependent mechanisms do not regulate receptor‐mediated phosphoinositide hydrolysis in BTSM.
Book ChapterDOI

Potential novel therapies for chronic obstructive pulmonary disease.

TL;DR: The inflammatory response in COPD is essentially steroid-resistant so that alternative anti-inflammatory treatments are needed and new therapeutic approaches to prevent disease progression are urgently needed.